Bruno Royer

High-Dose Melphalan versus Melphalan plus Dexamethasone for AL Amyloidosis

Arnaud Jaccard, Philippe Moreau, Véronique Leblond et al. · New England Journal of Medicine · 2007 · 514 citations

Minimal residual disease negativity using deep sequencing is a major prognostic factor in multiple myeloma

Aurore Perrot, Valérie Lauwers‐Cancès, Jill Corre et al. · Blood · 2018 · 408 citations · Full text

High-Dose Therapy and Autologous Blood Stem-Cell Transplantation Compared With Conventional Treatment in Myeloma Patients Aged 55 to 65 Years: Long-Term Results of a Randomized Control Trial From the Group Myelome-Autogreffe

Jean‐Paul Fermand, Sandrine Katsahian, Marine Diviné et al. · Journal of Clinical Oncology · 2005 · 400 citations · Full text

Lymphomas in Patients With Sjogren's Syndrome Are Marginal Zone B-Cell Neoplasms, Arise in Diverse Extranodal and Nodal Sites, and Are Not Associated With Viruses

Bruno Royer, Dominique Cazals‐Hatem, Jean Sibilia et al. · Blood · 1997 · 346 citations · Full text

Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies

Alain Fischer, Johan Provot, Jean-Philippe Jaı̈s et al. · Journal of Allergy and Clinical Immunology · 2017 · 304 citations

Primary Immunodeficiency, Rheumatology, Inflammation +14